Cresilon
BROOKLYN, NY · Biotechnology · 88 employees
Cresilon, Inc. is a privately held medical device company headquartered in Brooklyn, New York, specializing in hemostatic technologies designed to improve wound care and elevate the standard of medical treatment.
Funding history
- Series seed — $5.0M — Apr 2026
- Funding Round — $6.7M — Dec 2025
- Funding Round — $17.2M — Sep 2025
- Funding Round — $25.0M — Jan 2025
- Funding Round — $17.2M — Oct 2024
Recent signals
- Apr 29, 2026: Raised $5.0M in Series seed
- Dec 08, 2025: Raised $6.7M
- Sep 05, 2025: Raised $17.2M
- Jan 31, 2025: Raised $25.0M
- Oct 08, 2024: Raised $17.2M
- Oct 27, 2022: Raised $25.0M in Series series a
- Oct 18, 2022: Raised $25.0M
- Jan 12, 2018: Raised $13.3M
See plans & pricing → Track Cresilon’s funding, hiring, and signals — with verified contacts — on Fundz.